ClinicalTrialsFinder

Urinary Bladder Cancer Clinical Trials in Amsterdam, North Holland

1 recruitingAmsterdam, North Holland, Netherlands

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study

Urinary Bladder CancerInvasive Bladder Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)50 enrolled3 locationsNCT03844256